Delta Accumulation LLC’s Bristol-Myers Squibb BMY Stock Holding History

Delta Accumulation LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-33,500	Closed	-$1.73M	–	199
2025 Q3	$1.73M	Sell	33,500 -18,600	-36%	-$869K	0.11%	117
2025 Q2	$2.7M	Sell	52,100 -20,300	-28%	-$996K	0.2%	87
2025 Q1	$3.75M	Sell	72,400 -49,100	-40%	-$2.86M	0.22%	74
2024 Q4	$6.29M	Buy	121,500 +64,700	+114%	+$3.62M	0.35%	47
2024 Q3	$2.94M	Sell	56,800 -12,200	-18%	-$572K	0.22%	67
2024 Q2	$2.87M	Buy	69,000 +3,400	+5%	+$152K	0.21%	54
2024 Q1	$3.56M	Sell	65,600 -49,400	-43%	-$2.52M	0.25%	65
2023 Q4	$7.35M	Buy	115,000 +60,300	+110%	+$3.17M	1.16%	28
2023 Q3	$3.17M	Buy	54,700 +25,200	+85%	+$1.54M	0.71%	47
2023 Q2	$1.89M	Buy	29,500 +12,700	+76%	+$852K	0.64%	43
2023 Q1	$1.16M	Buy	16,800 +8,400	+100%	+$592K	0.71%	55
2022 Q4	$604K	Buy	+8,400	New	+$633K	0.63%	58
2022 Q1	–	Sell	-48,200	Closed	-$3M	–	144
2021 Q4	$3M	Buy	+48,200	New	+$2.83M	0.3%	74

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Delta Accumulation LLC's BMY Position: Q1 2026 in Review

Delta Accumulation LLC held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 2 shares worth $121. The position accounts for ﹤0.01% of the portfolio, ranked #87.

Delta Accumulation LLC first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $419K in Q4 2024. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Delta Accumulation LLC held 2 shares of Bristol-Myers Squibb worth $121 as of Q1 2026.
Delta Accumulation LLC left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up ﹤0.01% of Delta Accumulation LLC's portfolio in Q1 2026, its #87 holding.
Delta Accumulation LLC first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
Delta Accumulation LLC's Bristol-Myers Squibb position peaked at $419K in Q4 2024.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Delta Accumulation LLC's 13F filing for Q1 2026, filed 8 May 2026.